{"schema_version":"secwatch.filing_event.v1","accession":"0001757898-24-000017","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.492301+00:00","generated_at":"2026-05-30T04:41:25.087513+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"STERIS Q2 adjusted EPS $2.14, revenue $1.3B (+7%); reiterates FY2025 outlook","bullets":["Adjusted EPS from continuing operations $2.14 vs $1.86 prior year; as-reported EPS $1.51 vs $1.20.","Total revenue $1.3B, +7% as reported and constant currency organic growth.","Healthcare revenue +9% to $944.2M, driven by consumables (+12%) and service (+14%); capital equipment -2%.","AST revenue +9% to $256.7M; Life Sciences revenue -4% to $127.9M due to divestiture, organic +3%.","FY2025 outlook reiterated: revenue growth 6.5-7.5%, adjusted EPS $9.05-$9.25, free cash flow ~$700M."],"urls":{"canonical":"https://secwatch.observer/filing/0001757898-24-000017","json":"https://secwatch.observer/filing/0001757898-24-000017.json","markdown":"https://secwatch.observer/filing/0001757898-24-000017.md","text":"https://secwatch.observer/filing/0001757898-24-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000175789824000017/0001757898-24-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000175789824000017/ste-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:41:25.087513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}